Trial Profile
Registry for Estimation of Warfarin and Rivaroxaban in Atrial Fibrillation Patients With Coronary Stent Implantation (REWRAPS:prospective observational study)
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 26 Oct 2016
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary) ; Warfarin
- Indications Cardiovascular disorders; Myocardial infarction; Stroke; Venous thromboembolism
- Focus Adverse reactions; Therapeutic Use
- Acronyms REWRAPS Study
- 26 Oct 2016 New trial record